miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes

Cell Reports
Keita TsujimuraKinichi Nakashima

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations. Although emerging evidence suggests that MeCP2 deficiency is associated with dysregulation of mechanistic target of rapamycin (mTOR), which functions as a hub for various signaling pathways, the mechanism underlying this association and the molecular pathophysiology of RTT remain elusive. We show here that MeCP2 promotes the posttranscriptional processing of particular microRNAs (miRNAs) as a component of the microprocessor Drosha complex. Among the MeCP2-regulated miRNAs, we found that miR-199a positively controls mTOR signaling by targeting inhibitors for mTOR signaling. miR-199a and its targets have opposite effects on mTOR activity, ameliorating and inducing RTT neuronal phenotypes, respectively. Furthermore, genetic deletion of miR-199a-2 led to a reduction of mTOR activity in the brain and recapitulated numerous RTT phenotypes in mice. Together, these findings establish miR-199a as a critical downstream target of MeCP2 in RTT pathogenesis by linking MeCP2 with mTOR signaling.

References

Apr 1, 1995·Neuropediatrics·M L BaumanD M Arin
Jan 5, 2002·The American Journal of Psychiatry·David CohenDelphine Héron
Mar 9, 2002·American Journal of Human Genetics·Sabine M KlauckAnnemarie Poustka
Apr 8, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sandra LuikenhuisRudolf Jaenisch
Nov 9, 2004·Nature·Richard I GregoryRamin Shiekhattar
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Vardhan S DaniSacha B Nelson
Oct 18, 2005·Journal of Child Neurology·Daniel G Glaze
Oct 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Juan I YoungHuda Y Zoghbi
Apr 4, 2006·Current Biology : CB·Erika D NelsonLisa M Monteggia
Nov 9, 2007·Neuron·Maria Chahrour, Huda Y Zoghbi
Oct 11, 2008·Nature Reviews. Cancer·Bradly G Wouters, Marianne Koritzinsky
Nov 6, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Tokumitsu WatanabeTakashi Nakaoka
Nov 26, 2008·Nucleic Acids Research·Youn-Bok LeeJames B Uney
Feb 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daniela TropeaMriganka Sur
Feb 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jifang TaoYi Eve Sun
Feb 24, 2009·Nature Neuroscience·Nurit BallasGail Mandel
Feb 20, 2010·PloS One·Hiyaa Singhee GhoshPaul D Robbins
Apr 7, 2010·The Journal of Cell Biology·Keith E SzulwachPeng Jin
Apr 16, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Izumi Maezawa, Lee-Way Jin
Jan 8, 2011·Human Molecular Genetics·Sara RicciardiVania Broccoli
Jan 1, 2010·Frontiers in Synaptic Neuroscience·Elena M BoggioMaurizio Giustetto
Feb 23, 2012·Scientific Reports·Silvia LandiGian Michele Ratto
Mar 20, 2012·The Journal of Clinical Investigation·Arin B AuroraEric N Olson
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
May 10, 2012·Cell Reports·Chong Yon ParkMichael T McManus
Sep 17, 2013·Cell·Alison C Lloyd
Oct 30, 2013·Nature Neuroscience·Mauro Costa-Mattioli, Lisa M Monteggia
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Mitsugu Shimobayashi, Michael N Hall

❮ Previous
Next ❯

Citations

Mar 5, 2016·Neural Plasticity·Danielle FeldmanMriganka Sur
Jan 7, 2016·Frontiers in Molecular Neuroscience·Anne BieverEmma Puighermanal
Oct 16, 2016·Scientific Reports·Stefanie G Wohl, Thomas A Reh
Feb 18, 2017·Scientific Reports·Tian-Lin ChengZilong Qiu
May 26, 2017·Human Mutation·Rahul KrishnarajJohn Christodoulou
Dec 1, 2017·Cell and Tissue Research·Tomohisa Toda, Fred H Gage
Feb 27, 2016·F1000Research·Michael JohnstonSakkubai Naidu
Feb 12, 2020·Medicinal Research Reviews·Vibhuti JoshiAmit Mishra
Jan 5, 2019·Rinshō shinkeigaku = Clinical neurology·Hidekazu Kato, Norio Ozaki
Jan 6, 2019·Molecular Diagnosis & Therapy·Alessia FinottiRoberto Gambari
Nov 15, 2019·Nucleic Acids Research·Geoffray MonteuuisJohn E J Rasko
Feb 13, 2019·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Tetsuro Yasui, Kinichi Nakashima
Aug 6, 2019·Frontiers in Integrative Neuroscience·Victor FaundezDaniel Tarquinio
Apr 30, 2016·The Journal of Biological Chemistry·Koichiro IrieKinichi Nakashima
Apr 22, 2018·Molecular Psychiatry·Tomohisa TodaFred H Gage
Jul 6, 2017·Development·Marek Rajman, Gerhard Schratt
Jan 25, 2021·Archives of Biochemistry and Biophysics·Jiao WangKun Huang
Feb 9, 2021·Frontiers in Genetics·Katrina V GoodJuan Ausió
May 13, 2021·EMBO Reports·Francesco Longo, Eric Klann
Mar 24, 2018·Cell·David P Bartel
Feb 28, 2021·Journal of Neurochemistry·Santosh R D'Mello
Nov 23, 2021·Frontiers in Neuroscience·Julia Reichard, Geraldine Zimmer-Bensch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.